SCHEMBL26326648

SCHEMBL26326648

CC(O)(CCc1ccccc1)c1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 2/20 0.47
CYP1A2 P05177 1/20 0.47
CYP2C9 P11712 1/20 0.47
ALDH1A1 P00352 2/20 0.44
HPGD P15428 1/20 0.44
ALOX15 P16050 1/20 0.44
ALOX12 P18054 1/20 0.44
CASP1 P29466 1/20 0.44
HSD17B10 Q99714 1/20 0.44
TDP1 Q9NUW8 1/20 0.43
KMT2A Q03164 1/20 0.41
SLC6A4 P31645 1/20 0.41
SLC6A3 Q01959 1/20 0.41
HSP90AA1 P07900 1/20 0.41
CDK1 P06493 1/20 0.41
CCNB1 P14635 1/20 0.41
KIF11 P52732 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26326646 0.89 KMT2A (0.47) ALDH1A1TDP1KMT2AKIF11SMN1; SMN2
SCHEMBL9589436 0.87 CYP1A2 (0.42) CYP2C19CYP1A2CYP2C9SMN1; SMN2
SCHEMBL3190736 0.84 CYP2C19 (0.48) CYP2C19CYP1A2CYP2C9ALDH1A1ALOX15
SCHEMBL10235671 0.82 PPARG (0.43) KIF11
SCHEMBL612966 0.81 KIF11 (0.48) CYP2C19CYP2C9KIF11
SCHEMBL10617967 0.80 CYP2C19 (0.46) CYP2C19CYP1A2CYP2C9ALDH1A1ALOX15
SCHEMBL272368 0.80 TDP1 (0.48) ALDH1A1HPGDALOX15ALOX12CASP1
SCHEMBL251220 0.80 TDP1 (0.48) ALDH1A1HPGDALOX15ALOX12CASP1
SCHEMBL3190448 0.80 SIGMAR1 (0.47) CYP2C19ALDH1A1ALOX15SLC6A4SLC6A3
SCHEMBL3200007 0.80 CYP2C19 (0.50) CYP2C19ALDH1A1ALOX15KMT2ASLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101537333-B Redispersible submicron polymer hollow capsule and preparation method thereof UNIV ZHEJIANG 2012-03-21 CN claimed
CN-101537333-A Redispersible submicron polymer hollow capsule and preparation method thereof UNIV ZHEJIANG 2009-09-23 CN claimed
US-20230271988-A1 METHOD FOR PRODUCING ORGANOMETALLIC NUCLEOPHILE AND REACTION METHOD USING ORGANOMETALLIC NUCLEOPHILE NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY (JP) 2023-08-31 US disclosed
US-20230271988-A1 METHOD FOR PRODUCING ORGANOMETALLIC NUCLEOPHILE AND REACTION METHOD USING ORGANOMETALLIC NUCLEOPHILE NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY (JP) 2023-08-31 US disclosed
CN-101537333-B Redispersible submicron polymer hollow capsule and preparation method thereof UNIV ZHEJIANG 2012-03-21 CN disclosed
CN-101537333-A Redispersible submicron polymer hollow capsule and preparation method thereof UNIV ZHEJIANG 2009-09-23 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230271988-A1 METHOD FOR PRODUCING ORGANOMETALLIC NUCLEOPHILE AND REACTION METHOD USING ORGANOMETALLIC NUCLEOPHILE HPD, TALDO1, OGG1 CYP2C19 970/4885CYP1A2 537/4885CYP2C9 241/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.